Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
For the nine months, sales was USD 0.912103 million compared to USD 0.471148 million a year ago. Net loss was USD 1.15 million compared to USD 0.430301 million a year ago. Basic loss per share from continuing operations was USD 0.01.